Cure My Disease

Don't miss your cure!

 Log in / Sign up

New vaccine-immunotherapy combo aims to shrink head and neck tumors before surgery

NCT ID NCT07572864

Not yet recruiting Disease control Sponsor: West China Hospital Source: ClinicalTrials.gov ↗

First seen May 09, 2026 · Last updated May 09, 2026

Summary

This study tests a new treatment for head and neck cancer that combines an experimental vaccine with immunotherapy. The vaccine is designed to train the immune system to attack cancer cells, while the immunotherapy helps remove the brakes on immune cells. The treatment is given before and after surgery to try to shrink tumors and prevent the cancer from coming back. The study will include 9 adults with a specific type of head and neck cancer that can be removed with surgery.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEAD AND NECK SQUAMOUS CELL CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Email: •••••@•••••

Locations

  • West China Hospital, Sichuan University

    Chengdu, Sichuan, 610041, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

HEAD AND NECK SQUAMOUS CELL CARCINOMA